|
|
|
|
PATENTS
Novinium employees have conceived and developed virtually all of the commercially significant cable
rejuvenation technology used around the world over the last 22 years. Since 2002 when the early
seeds of Novinium were planted, these same inventors have been continually advancing the state-of-the-art
– Safer … Faster … Better. The advanced technologies practiced by Novinium, its partners, and its licensees
are Novinium’s exclusive intellectual property and are protected by at least 10 granted or pending patents
including, but not limited to, the following published patents, published patent applications, or unpublished
applications and the foreign equivalents thereof:
- Ultrinium™ sustained pressure injection method (Patent 7,615,247)
- Ultrinium™ formulation optimization injection method (Patent 7,611,748)
- Injection Adaptor (U.S. Patent 7,195,504 and 7,538,274)
- Perfectium™ single visit, single switch injection (U.S. Patent 7,353,601)
- Formulation of Ultrinium™ & Perficio™ components (patent pending: US20080223498 and US20080173467)
- Predicting performance of Electrical Power cables (U.S. Patent 7,643,977)
- N-Rex™ submarine cable injection process (patent pending)
- N-Ter™ injection or Novinium thermally enhanced rejuvenation (patent pending)
- Reticular Flash Preventer (RFP) provides safer operation of conventional injection elbows (patent pending)
Copies of the published documents cited above are available from the U.S. Patent and Trademark office.
The Novinium commitment to R&D continues and new patented technology will be rolled out as those novel
advances are reduced to practice. For inquiries regarding licensing Novinium technology, send your contact
information and the nature of your request to ip@novinium.com.
|
|
|
|
|